Evaluation of serial monthly estimated glomerular filtration rate (eGFR) ma
y be useful for studying pediatric renal allograft outcome. To determine th
e validity of this approach, we reviewed our single-center experience in pe
diatric renal transplant recipients to determine the effect of risk factors
for renal allograft failure on eGFR. Clinical parameters recorded monthly
through 5 years post transplant allowed serial assessment of eGFR. Monthly
clinical data included height, weight, serum creatinine, cumulative number
of acute rejection episodes, cyclosporine dose, and cyclosporine trough lev
els. From these data, eGFR was calculated monthly for each patient using th
e Schwartz formula. Time post transplant was grouped in 6-month intervals a
nd plotted against mean eGFR to compare eGFR in patients grouped by demogra
phic and clinical factors; 1,786 monthly data sets from 6 months post trans
plant (n=76 patients) to 5 years post transplant (n=25 patients) were analy
zed. Overall mean eGFR from 6 months to 1 year was 75 ml/min per 1.73 m(2)
and from 4.5 to 5 years 46 ml/min per 1.73 m(2), eGFR was lower at all time
intervals for recipients of cadaver versus living-related donor grafts, an
d patients with greater than or equal to 1 versus 0 acute rejections (P<0.0
1). After 1 year, eGFR was lower in black patients compared with white or H
ispanic patients (P<0.01). Cy closporine dose greater than 5 mg/kg per day
was associated with better early and worse late graft function. These resul
ts are similar to those reported in multi-center studies using the outcome
variable of graft failure and suggest that serial eGFR may be valid as an o
utcome variable to study chronic renal allograft dysfunction in children.